Addressing tobacco addiction is a crucial component of comprehensive patient care. As healthcare professionals, we play a pivotal role in guiding patients through smoking cessation.
First-line medications such as nicotine replacement therapy (NRT), bupropion, and varenicline have been proven significantly effective. They are recommended for all patients attempting to quit, unless contraindicated.
Combining pharmacotherapy with behavioural interventions enhances success rates. Cognitive-behavioural therapy, motivational interviewing, and self-help resources can help patients to cope with cravings and withdrawal symptoms.
Intensive intervention programs involving multiple sessions over a prolonged period have shown higher success rates compared to less intensive interventions. Such programs often include a combination of medication, behavioural therapy, and support groups.
Regular follow-ups are essential to assess progress, manage withdrawal symptoms, and prevent relapse. Encouragement and reinforcement of smoke-free behaviour are vital during this phase.
Smoking cessation requires a multifaceted approach. By integrating pharmacological strategies, behavioural interventions, intensive intervention programs, and consistent follow-up, we can significantly enhance our patients' chances of successfully quitting smoking.
1.
NPM1-Mutated AML: Not All Treatments Are Equal
2.
Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey
3.
MRI can save rectal cancer patients from surgery, study suggests
4.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
5.
Rising rates of head and neck cancers in England
1.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
2.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
3.
Molecular Classification of Refractory Anemia: A Comprehensive Review
4.
Ferroptosis-Modulating Therapeutics in Precision Oncology
5.
Blood-Cell Morphology Foundation Models: Transforming Hematological Diagnostics and Clinical Practice
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Thromboprophylaxis In Medical Settings- An Update
3.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
4.
How Platelet Disorders Can Affect the Body
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation